We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Immunology – Products

Two medical professionals looking at a computer screen.
Product News

Oncodesign Services Announce Access to ImaginAb’s CD8 ImmunoPET™ Technology

Oncodesign Services announces the execution of a Preclinical License and Supply Agreement with ImaginAb Inc. for the use of their investigational CD8 ImmunoPET™ (89Zr crefmirlimab berdoxam) technology.
Cell and Gene Therapy Applications
Compendium

Cell and Gene Therapies: Innovations and Applications

Cell and gene therapies seek to correct the root cause of an illness at the molecular level. These game-changing medicines are reshaping how we address previously untreatable illnesses – transforming people’s lives.
BAMS RMM particle counter.
Product News

Cherwell To Highlight How Expanding EM Portfolio Solves Annex 1 Challenges at Cell & Gene Therapy Conference

New RMM system addition to product range means Cherwell can fully support EM programmes for Annex 1 compliant contamination control strategies.
TriLink Biotechnologies logo.
Product News

TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion As mRNA Manufacturing Facility Nears Completion

TriLink’s construction of the new 32,000-square-foot, cGMP-grade facility solidifies its commitment to advancing the field as more mRNA-based therapeutics and vaccines enter later-stage clinical trials.
Oncohost logo.
Product News

OncoHost To Present PROphet® Biomarker Model That Accurately Predicts Clinical Benefit to ICI-Based Treatment

OncoHost has announced that it will give a poster presentation demonstrating the accuracy of its PROphet® biomarker model at the upcoming American Society of Clinical Oncology Annual Meeting, taking place June 2-6, 2023, in Chicago, Illinois.
The new M Bio building.
Product News

Cell and Gene Therapy CDMO Targets North American Growth With Major US Acquisition

uBriGene, a cell & gene therapy contract development and manufacturing organization, is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc.
T cells attacking a cancer cell.
Product News

Efficient Transduction of CAR Into T Cells

AMSBIO announce a new range of high-titer Chimeric Antigen Receptor (CAR) lentivirus that provide high transduction efficiency with long-term, stable expression in resting and actively dividing cells.
The TheraPEAK® T-VIVO® Cell Culture Medium.
Product News

Lonza Launches TheraPEAK® T-VIVO® Cell Culture Medium To Accelerate Cell Therapy Development

Lonza has launched the TheraPEAK® T-VIVO® Cell Culture Medium, a novel chemically defined medium developed to optimize CAR T-cell manufacture.
The Personalis logo
Product News

Personalis, National Cancer Center Hospital East and Ono Collaborate To Better Predict Immunotherapy Response for Rectal Cancer

Personalis, Inc., National Cancer Center and Ono Pharmaceutical Co., Ltd. have announced they have entered into a collaborative agreement to examine the efficacy and safety of nivolumab, an immune checkpoint inhibitor, for resectable rectal cancer with mismatch repair deficiency.
Promising Target Antigens for Cell Therapy of Solid Tumors content piece image
Product
Advertisement

Promising Target Antigens for Cell Therapy of Solid Tumors

Sino Biological provides a comprehensive range of reagents and services to support the development of CAR-T therapies targeting solid tumors.
Advertisement